Donoghue Forlines LLC Buys New Stake in Molina Healthcare, Inc. (NYSE:MOH)

Donoghue Forlines LLC acquired a new position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,647 shares of the company's stock, valued at approximately $1,318,000.

Other hedge funds have also made changes to their positions in the company. Annis Gardner Whiting Capital Advisors LLC acquired a new stake in shares of Molina Healthcare during the 3rd quarter valued at about $30,000. McIlrath & Eck LLC acquired a new stake in Molina Healthcare in the 4th quarter valued at $34,000. VisionPoint Advisory Group LLC lifted its holdings in shares of Molina Healthcare by 105.6% during the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company's stock valued at $36,000 after acquiring an additional 57 shares during the period. Raleigh Capital Management Inc. boosted its stake in shares of Molina Healthcare by 40.4% in the 3rd quarter. Raleigh Capital Management Inc. now owns 125 shares of the company's stock valued at $41,000 after purchasing an additional 36 shares in the last quarter. Finally, Principal Securities Inc. bought a new stake in shares of Molina Healthcare in the 4th quarter worth about $42,000. Institutional investors own 98.50% of the company's stock.

Analyst Ratings Changes

Several brokerages have weighed in on MOH. Wells Fargo & Company decreased their price objective on shares of Molina Healthcare from $410.00 to $375.00 and set an "equal weight" rating on the stock in a research note on Monday, April 29th. Barclays cut their price target on Molina Healthcare from $437.00 to $430.00 and set an "equal weight" rating for the company in a report on Thursday, April 25th. Bank of America lowered shares of Molina Healthcare from a "neutral" rating to an "underperform" rating and set a $439.00 price objective on the stock. in a report on Thursday, March 28th. StockNews.com cut shares of Molina Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Thursday, February 8th. Finally, Truist Financial boosted their price objective on shares of Molina Healthcare from $435.00 to $460.00 and gave the stock a "buy" rating in a research report on Tuesday, February 20th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, Molina Healthcare presently has a consensus rating of "Hold" and a consensus price target of $404.90.

Insider Transactions at Molina Healthcare

In other Molina Healthcare news, Director Richard M. Schapiro sold 711 shares of the stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the completion of the sale, the director now directly owns 12,207 shares in the company, valued at $4,688,220.42. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Molina Healthcare news, Director Richard M. Schapiro sold 711 shares of the stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $384.06, for a total transaction of $273,066.66. Following the completion of the transaction, the director now owns 12,207 shares in the company, valued at approximately $4,688,220.42. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Mark Lowell Keim sold 15,000 shares of Molina Healthcare stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the sale, the chief financial officer now directly owns 36,531 shares in the company, valued at approximately $14,121,423.36. The disclosure for this sale can be found here. Insiders have sold a total of 16,711 shares of company stock valued at $6,472,517 over the last three months. 1.10% of the stock is currently owned by corporate insiders.

Molina Healthcare Trading Up 1.3 %

Shares of Molina Healthcare stock traded up $4.57 during trading on Friday, reaching $354.60. 360,182 shares of the company were exchanged, compared to its average volume of 459,158. Molina Healthcare, Inc. has a twelve month low of $266.35 and a twelve month high of $423.92. The business has a 50-day moving average price of $379.30 and a 200-day moving average price of $372.12. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $20.78 billion, a price-to-earnings ratio of 19.24, a P/E/G ratio of 1.09 and a beta of 0.54.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, April 24th. The company reported $5.73 EPS for the quarter, beating analysts' consensus estimates of $5.46 by $0.27. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The company had revenue of $9.93 billion during the quarter, compared to analysts' expectations of $9.45 billion. During the same period in the prior year, the business posted $5.81 EPS. Molina Healthcare's revenue was up 21.9% on a year-over-year basis. Sell-side analysts anticipate that Molina Healthcare, Inc. will post 23.59 EPS for the current fiscal year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.